Efficacy of utilizing cannabidiol in reduction of inflammation and autoimmunity manifestation
1 adjunct professor of OMFS Department of Augusta University, GA, USA.
2 craniofacial reconstruction and trauma Queen Marry, University of London, London, Great Britain.
3 Department of Molecular Medicine, University of Padua, Italy.
4 Golestan Medical science University, Iran.
5 Shahid Beheshti University of medical science, Dental School, Tehran, Iran.
Review Article
Open Access Research Journal of Biology and Pharmacy, 2022, 04(01), 040–047.
Article DOI: 10.53022/oarjbp.2022.4.1.0020
Publication history:
Received on 22 December 2021; revised on 31 January 2022; accepted on 02 Februay 2022
Abstract:
This article reviews recent research on cannabinoids that mediate anti-inflammatory effects through cannabinoid receptors. Inflammation is involved in many of the diseases. Chronic inflammation can be caused by cancer, autoimmune disorders, and untreated infections. Some factors like smoking, obesity, or stress may also be caused by chronic inflammation. Early researchers show that Cannabidiol (CBD) has a significant role in reducing inflammation. Cannabis sativa is most commonly used for its medicinal and anti-inflammatory properties. This article focuses primarily on using cannabinoids as a new class of anti-inflammatory agents against specific autoimmune diseases and inflammatory responses caused by cell-mediated immune compounds or activated T cells.
Keywords:
Medicinal Cannabis; Inflammation; Autoimmunity; Therapeutic potential
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0